More recently, many studies identified IGFBP2 as an EMT-driver gene that promotes the proliferation and migration of colorectal cancer cells through E-cadherin inhibition [30] or the hepatocellular carcinoma progression by activation of the NF-κB-ZEB1 signaling axis [13]. The gene discussed is IGFBP2; the disease is hepatocellular carcinoma.